John C. Hutton
Affiliations: | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Cell BiologyGoogle:
"John Hutton"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wenzlau JM, Fain PR, Gardner TJ, et al. (2015) ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium Study. Diabetes Care. 38: S29-36 |
Wenzlau JM, Frisch LM, Hutton JC, et al. (2015) Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop. Diabetes Care. 38: S14-20 |
Vendrame F, Hopfner YY, Diamantopoulos S, et al. (2015) Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons |
Brorsson CA, Onengut S, Chen WM, et al. (2015) Novel association between immune-mediated susceptibility loci and persistent autoantibody positivity in type 1 diabetes. Diabetes |
Asanghanwa M, Gorus FK, Weets I, et al. (2014) Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients. Diabetes Research and Clinical Practice. 103: 97-105 |
Wenzlau JM, Hutton JC. (2013) Novel diabetes autoantibodies and prediction of type 1 diabetes. Current Diabetes Reports. 13: 608-15 |
Mbunwe E, Auwera BJVd, Weets I, et al. (2013) In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions Diabetologia. 56: 1964-1970 |
Pound LD, Oeser JK, O'Brien TP, et al. (2013) G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes. 62: 1547-56 |
Gorus FK, Balti EV, Vermeulen I, et al. (2013) Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients. Clinical and Experimental Immunology. 171: 82-90 |
Mbunwe E, Van der Auwera BJ, Vermeulen I, et al. (2013) HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients. Diabetes. 62: 1345-50 |